Page 4 - Bdtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bdtx Today - Breaking & Trending Today

FY2027 Earnings Estimate for Black Diamond Therapeutics, Inc. Issued By Wedbush (NASDAQ:BDTX)

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) – Equities research analysts at Wedbush increased their FY2027 earnings per share estimates for shares of Black Diamond Therapeutics in a research note issued on Tuesday, May 9th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of $0.22 per share for the year, […] ....

Vanguard Group Inc , Blackrock Inc , Healthcare Of Ontario Pension Plan Trust Fund , Diamond Therapeutics Inc , Diamond Therapeutics Company Profile , Millennium Management , Black Diamond Therapeutics , Get Rating , Black Diamond Therapeutic , Diamond Therapeutics , Ontario Pension Plan Trust Fund , Black Diamond Therapeutics Daily , Nasdaq Bdtx , Earnings Estimates ,

Black Diamond Therapeutics (NASDAQ:BDTX) versus Alector (NASDAQ:ALEC) Critical Survey

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) and Alector (NASDAQ:ALEC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership. Risk and Volatility Black Diamond Therapeutics has a beta […] ....

United Kingdom , United States , Tillmanu Gerngross , Errikb Anderson , Arnon Rosenthal , Asa Abeliovich , Therapeutics Inc , Alector Inc , Openeye Scientific Software Inc , Diamond Therapeutics Inc , Black Diamond Therapeutics , Get Rating , Diamond Therapeutics , Given Alector , Black Diamond , Openeye Scientific Software , South San Francisco , Black Diamond Therapeutics Daily , Nasdaq Bdtx , Stock Comparison , Stock Analysis ,

Black Diamond Therapeutics (NASDAQ:BDTX) Stock Price Down 5%

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) shares were down 5% during mid-day trading on Tuesday . The company traded as low as $1.45 and last traded at $1.51. Approximately 34,809 shares changed hands during mid-day trading, a decline of 68% from the average daily volume of 107,811 shares. The stock had previously closed […] ....

Renaissance Technologies , Vanguard Group Inc , Diamond Therapeutics Inc , Millennium Management , Jpmorgan Chase Co , Healthcare Of Ontario Pension Plan Trust Fund , Black Diamond Therapeutics , Get Rating , Diamond Therapeutics , Black Diamond , Ontario Pension Plan Trust Fund , Black Diamond Therapeutics Daily , Nasdaq Bdtx ,

Black Diamond Therapeutics (NASDAQ:BDTX) and La Jolla Pharmaceutical (NASDAQ:LJPC) Head to Head Survey

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) and La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Volatility & Risk Black Diamond Therapeutics has […] ....

United States , United Kingdom , Jolla Pharmaceutical Company , Therapeutics Inc , Diamond Therapeutics Inc , Openeye Scientific Software Inc , Everest Medicines , Black Diamond Therapeutics , Get Rating , Diamond Therapeutics , Jolla Pharmaceutical , Black Diamond , Given Black Diamond Therapeutic , Openeye Scientific Software , Everest Medicines Limited , Nasdaq Bdtx , Stock Comparison , Stock Analysis ,

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Major Shareholder Growth N. V. Biotech Buys 150,000 Shares

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) major shareholder Growth N. V. Biotech acquired 150,000 shares of the business’s stock in a transaction on Monday, April 18th. The shares were purchased at an average cost of $3.29 per share, for a total transaction of $493,500.00. Following the completion of the acquisition, the insider now […] ....

Stifel Nicolaus , Morgan Stanley , Securities Exchange Commission , Zacks Investment Research , Norges Bank , Renaissance Technologies , Bioimpact Capital , Capital Management , Diamond Therapeutics Inc , Black Diamond Therapeutics , Get Rating , Exchange Commission , Diamond Therapeutics , Impact Capital , Investment Research , Nasdaq Bdtx , Insider Trading , Nsider Trades ,